Cargando…
Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia
Acute myeloid leukemia (AML) represents a major therapeutic challenge in the elderly. Because of the high treatment-related mortality and poor overall outcomes of remission induction therapy, many older patients are not considered candidates for intensive chemotherapy. The current study evaluated pr...
Autores principales: | Ross, Kelly, Gillespie-Twardy, Amanda L., Agha, Mounzer, Raptis, Anastasios, Hou, Jing-Zhou, Farah, Rafic, Redner, Robert L., Im, Annie, Duggal, Shrina, Ding, Fei, Lin, Yan, Boyiadzis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838424/ https://www.ncbi.nlm.nih.gov/pubmed/25706395 http://dx.doi.org/10.3727/096504014X14146137738547 |
Ejemplares similares
-
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
por: Im, Annie, et al.
Publicado: (2016) -
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission
por: Patel, Arisha, et al.
Publicado: (2021) -
Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016) -
PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
por: Siala, N., et al.
Publicado: (2022) -
The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)